drug

New Business

DeepSeek addition to ClouDr medical AI platform drives share-price surge

Shares of Chinese digital healthcare company ClouDr Group surged for a second day after it announced that it has embedded…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Tech

Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts

An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…

Read More »
Back to top button